1.57
+0(+0.00%)
Currency In USD
| Previous Close | 1.57 |
| Open | 1.55 |
| Day High | 1.62 |
| Day Low | 1.5 |
| 52-Week High | 3.51 |
| 52-Week Low | 1.45 |
| Volume | 51,683 |
| Average Volume | 75,610 |
| Market Cap | 178.34M |
| PE | -0.87 |
| EPS | -1.81 |
| Moving Average 50 Days | 1.73 |
| Moving Average 200 Days | 2 |
| Change | 0 |
If you invested $1000 in Waldencast plc (WALD) since IPO date, it would be worth $159.39 as of March 07, 2026 at a share price of $1.57. Whereas If you bought $1000 worth of Waldencast plc (WALD) shares 3 years ago, it would be worth $199.99 as of March 07, 2026 at a share price of $1.57.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
GlobeNewswire Inc.
Feb 27, 2026 1:33 PM GMT
Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excellence, rapid access to care, and dissemination across its extensive national network of practicesNEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Obagi M
Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
GlobeNewswire Inc.
Feb 25, 2026 1:26 PM GMT
It’s a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and outstanding patient results across its growing network of high-end locationsNEW YORK and DALLAS, Fe
Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
GlobeNewswire Inc.
Feb 17, 2026 1:28 PM GMT
Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency, and supporting thousands of aesthetic practices nationwideNEW YORK and IRVING, Texas, Feb.